Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$2,816.2B | 7.0 | $434.5 14.7% undervalued | (8.1%) | $261.8B | $70.0B | 15.0% | 26.7% | 69.4% | 27.5% | 20.6% | |
$484.9B | 6.5 | $56.7 47.8% overvalued | 2.6% | $339.2B | $30.7B | 1.4% | 9.1% | 22.6% | 7.7% | 25.4% | |
$443.8B | 6.1 | $0.0 99.5% overvalued | (65.2%) | $216.7M | ($65.1M) | (2.9%) | (30.0%) | 57.1% | (27.2%) | 9.2% | |
$344.1B | 6.5 | $221.3 36.3% overvalued | (6.7%) | $159.5B | $16.3B | 4.5% | 10.2% | 33.0% | 21.2% | 207.9% | |
$338.0B | 7.1 | $71.6 5.7% overvalued | (42.7%) | DKK 290.4B | DKK 70.0B | 25.0% | 24.1% | 84.7% | 35.5% | 71.6% | |
$273.3B | 7.4 | $697.7 0.5% undervalued | (27.8%) | €28.3B | €9,084.6M | 2.6% | 32.1% | 51.3% | 27.8% | 19.9% | |
$217.2B | 6.5 | $284.8 37.2% overvalued | (3.7%) | $33.0B | $4,926.0M | (11.5%) | 14.9% | 42.2% | 9.8% | 56.7% | |
$203.7B | 6.1 | $149.1 0.5% undervalued | (7.3%) | $91.9B | $7,189.0M | 0.4% | 7.8% | 54.6% | 17.3% | 247.4% | |
$194.8B | 6.4 | $638.8 25.5% undervalued | (14.0%) | $42.9B | $7,267.0M | 0.1% | 16.9% | 41.5% | 7.9% | 63.0% | |
$187.8B | 5.7 | $0.0 99.7% overvalued | (84.1%) | £16.2M | (£43.9M) | (42.1%) | (270.5%) | 44.8% | (1,274.8%) | 0.1% | |
$168.7B | 7.5 | $275.2 81.1% undervalued | (8.4%) | $40.7B | $12.7B | 12.1% | 31.3% | 56.0% | 42.4% | 54.2% | |
$164.7B | 7.7 | $517.1 36.9% undervalued | (34.1%) | $22.0B | $9,181.0M | 10.5% | 41.7% | 89.0% | 37.6% | 3.1% | |
$162.8B | 6.8 | $617.6 6.2% undervalued | (10.7%) | $17.2B | $5,632.0M | 13.7% | 32.8% | 78.9% | 13.3% | 39.3% | |
$161.4B | 7.2 | $242.6 27.2% overvalued | (0.9%) | $64.8B | $8,820.0M | (3.4%) | 13.6% | 36.1% | 22.7% | 197.0% | |
$160.6B | 4.3 | $3.4 93.3% overvalued | (20.9%) | $11.8B | ($369.0M) | (15.9%) | (3.1%) | 18.2% | 4.9% | 95.7% | |
$159.2B | 7.0 | $77.4 21.1% overvalued | (49.6%) | $25.8B | $2,405.0M | 13.7% | 9.3% | 51.1% | 2.7% | 0.9% | |
$147.8B | 5.9 | $29.0 83.6% overvalued | 1.0% | $8,185.6M | $580.8M | (3.0%) | 7.1% | 38.0% | 9.7% | 42.1% | |
$147.5B | 6.0 | $159.6 21.8% overvalued | (19.7%) | $23.9B | $5,296.0M | (0.1%) | 22.2% | 59.5% | 5.9% | 32.3% | |
$145.1B | 6.1 | $28.1 9.8% undervalued | (3.6%) | $63.6B | $9,835.0M | 8.8% | 15.5% | 65.6% | 9.0% | 71.9% | |
$141.6B | 6.5 | $185.8 20.7% overvalued | (3.9%) | $24.3B | $5,894.0M | 0.5% | 24.3% | 45.5% | 24.0% | 190.2% |
Review premium stocks that beat benchmarks this week, offering consistent returns and stability.
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Explore the top weekly stock winners for 18 Mar 2025, outperforming the market and delivering gains.